PROPRIUS PHARMACEUTICALS

proprius-pharmaceuticals-logo

Proprius Pharmaceuticals is a San Diego-based drug developer focused on rheumatology and autoimmune diseases. The company offers two early clinical-stage therapeutic candidates comprising a product to treat pain and a product to treat rheumatoid arthritis. Proprius Pharmaceuticals was founded in 2005.

#SimilarOrganizations #People #Financial #Website #More

PROPRIUS PHARMACEUTICALS

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2005-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.propriuspharma.com

Total Employee:
1+

Status:
Closed

Contact:
858-436-1816

Total Funding:
11 M USD

Technology used in webpage:
Domain Not Resolving


Similar Organizations

aristea-therapeutics-logo

Aristea Therapeutics

Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.

merck-logo

Merck

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

orca-pharmaceuticals-logo

Orca Pharmaceuticals

Orca Pharmaceuticals is a new biotechnology startup focusing on treating autoimmune diseases.

Founder


not_available_image

David Anderson

Investors List

fog-city-capital_image

Fog City Capital

Fog City Capital investment in Series A - Proprius Pharmaceuticals

windamere-venture-partners_image

Windamere Venture Partners

Windamere Venture Partners investment in Series A - Proprius Pharmaceuticals

forward-ventures_image

Forward Ventures

Forward Ventures investment in Series A - Proprius Pharmaceuticals

cdib-ventures_image

CDIB BioScience Ventures

CDIB BioScience Ventures investment in Series A - Proprius Pharmaceuticals

atlas-venture_image

Atlas Venture

Atlas Venture investment in Series A - Proprius Pharmaceuticals

Official Site Inspections

http://www.propriuspharma.com

Unable to get host informations!!!

Loading ...

More informations about "Proprius Pharmaceuticals"

Proprius Pharmaceuticals - Crunchbase Company โ€ฆ

Proprius Pharmaceuticals is a San Diego-based drug developer focused on rheumatology and autoimmune diseases. The company offers two early โ€ฆSee details»

Proprius Pharmaceuticals - PitchBook

Information on acquisition, funding, cap tables, investors, and executives for Proprius Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»

Proprius Pharmaceuticals Inc - Company Profile and News

Company profile page for Proprius Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»

Proprius Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...

Explore Proprius Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 2 literature, Drug:PRO-515.See details»

Proprius Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

Headquarters Location. 12264 El Camino Real Suite 300. San Diego, California, 92130, United States. 858-436-1816See details»

PROPRIUS PHARMACEUTICALS, INC. - NPI 1730357658 - Clinical โ€ฆ

Feb 13, 2008 NPI Profile for Proprius Pharmaceuticals, Inc. in 12264 El Camino Real Ste 350 San Diego, Ca 92130. Phone: (858) 436-1816 . Taxonomy 291U00000XSee details»

Proprius Pharmaceuticals - Ownership and Business Overview

Feb 25, 2008 Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2008.The largest life science acquisition in 2008 was Alpharma Pharmaceuticals - which โ€ฆSee details»

Proprius Pharmaceuticals - CoBee Company Profile & Funding โ€ฆ

Proprius Pharmaceuticals is a San Diego-based drug developer focused on rheumatology and autoimmune diseases. The company offers two early clinical-stage therapeutic candidates โ€ฆSee details»

Proprius Pharmaceuticals Inc., Michael J. Walsh,

[email protected]: Phone: 1-858-436-1816: Website: www.propriuspharma.com Fax: 1-858-259-8941: Summary ; Executive Details ; Board Members ; Business Information The โ€ฆSee details»

Proprius Pharma - Founders and Board of Directors - Tracxn

Sep 28, 2024 Proprius Pharma founders & board of directors. Personalized medicine solutions in rheumatology and other autoimmune diseases. 2005 โ€ข San Diego (United States) โ€ข โ€ฆSee details»

Proprius Pharmaceuticals Secures Up To $17MM In Series A โ€ฆ

SAN DIEGO, Jan. 8 /PRNewswire/ -- Proprius Pharmaceuticals, Inc. today announced the completion of a Series A financing. The Series A round will provide Proprius with $11 million to โ€ฆSee details»

Proprius Pharmaceuticals, Inc. - SignalHire

Proprius Pharmaceuticals, Inc. is a biotechnology company based out of 12264El Camino Real, San Diego, California, United States.See details»

AlphaRx Inc.: Exhibit 99.1 - Prepared by TNT Filings Inc. - SEC.gov

Proprius is a privately-held and venture-backed organization, with financing provided by Fog City Fund, a life sciences fund established by St. Paul Venture Capital, and Windamere Venture โ€ฆSee details»

President & CEO - Proprius Pharmaceuticals, Inc. - LinkedIn

President & CEO at Proprius Pharmaceuticals, Inc. · Experience: Proprius Pharmaceuticals, Inc. · Location: San Diego · 1 connection on LinkedIn. View Michael Walshโ€™s profile on LinkedIn, a ...See details»

Proprius Pharmaceuticals Inc. Asset Profile | Preqin

Www.propriuspharma.com Company Stage Acquired Total Amount Raised Subscriber access only Time to go Pro Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on โ€ฆSee details»

Cypress Buying Proprius Pharma - PE Hub

Feb 26, 2008 Cypress Bioscience Inc. (Nasdaq: CYPB) has agreed to acquire Proprius Pharmaceuticals Inc., a San Diego-based drug developer focused on rheumatology and โ€ฆSee details»

Articles about Proprius Pharmaceuticals - BioSpace

Email: [email protected]. Show jobs for this employer 6 articles about Proprius Pharmaceuticals. Cypress Bioscience Inc. Closes Acquisition of Proprius Pharmaceuticals. โ€ฆSee details»

Proprius Pharmaceuticals - CB Insights

Explore {Proprius Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

Cypress inks $75M deal to acquire Proprius | Fierce Biotech

Feb 25, 2008 Cypress Bioscience has inked a deal to buy Proprius Pharmaceuticals in a deal that starts out at $37.5 million up front and goes up to $75 million if its gamble on new โ€ฆSee details»

AlphaRx Inc. And Proprius Pharmaceuticals Announce License

Apr 11, 2006 AlphaRx Inc. And Proprius Pharmaceuticals Announce License Agreement For Indaflex(TM), A Phase II Topical NSAID For Osteoarthritis - read this article along with other โ€ฆSee details»

linkstock.net © 2022. All rights reserved